The Helmholtz Centre for Infection Research and Evotec AG are joining forces in the development of new broadband antibiotics targeting Gram-negative pathogens. The research activities will initially
Fighting the global spread of antibiotic-resistant bacteria and developing new antibiotics is an important goal at the German Center for infection Research (DZIF). In order to further accelerate
Salt could be a key factor in allergic immune reactions. A team working with DZIF professor Christina Zielinski at the Technical University of Munich (TUM) has demonstrated in cell cultures that salt
Tuberculosis treatment still entails the intake several antibiotics over a period of many months and is torturous for many patients. The pathogen’s increasing multidrug resistance additionally
Millions of people have contracted Zika and chikungunya virus infections since the outbreaks that have been striking Latin America since 2013. Particularly Zika-related malformations in newborns
Many common antibiotics are increasingly losing their effectiveness against multi-resistant pathogens, which are becoming ever more prevalent. Bacteria use natural means to acquire mechanisms that
The rapid spread of antibiotic-resistant bacteria is calling infection researchers to action. Which mechanisms protect bacteria and which methods can make them vulnerable once again? In an article
CEPI (the Coalition for Epidemic Preparedness Innovations) supports the development and manufacture of a vaccine against Middle East Respiratory Syndrome Coronavirus (MERS-CoV), a zoonotic disease
An international research team led by the Research Center Borstel, developed a new method to label tubercle bacilli, the causative agents of tuberculosis with unique identifiers created from whole
New experiments conducted at the insectarium (high biosafety level 3) of the Bernhard Nocht Institute for Tropical Medicine (BNITM) and at the DZIF show that chikungunya viruses are able to replicate
